Canadian Researchers Create First Bovine TB Vaccine

Scientists at the University of Saskatchewan just solved a problem that's stumped researchers for decades: how to protect cattle from tuberculosis without making the disease impossible to detect.

The team at the Vaccine and Infectious Disease Organization created MSX-1, a vaccine that shielded 80 percent of test mice from a highly aggressive strain of bovine TB. Even better, it doesn't trigger false positives on the skin test farmers use to detect the disease.

That second part is crucial. An older vaccine called BCG protects perfectly but creates a major headache: vaccinated animals test positive for bovine TB even when they're healthy. MSX-1 sidesteps this problem entirely.

"If you vaccinate cattle with BCG down the road, you will not be able to distinguish between whether they were vaccinated or they've actually gotten infected," explained principal investigator Jeffrey Chen. His team's new approach changes everything.

Bovine tuberculosis has been spreading slowly across Prairie provinces since 2023, hitting herds in Alberta, Saskatchewan, and Manitoba. When the Canadian Food Inspection Agency finds the disease on a farm, the entire herd gets destroyed. Ranchers lose their livelihoods overnight.

The MSX-1 vaccine faced one of the most vicious TB strains researchers could throw at it in the lab. Since the strains found on actual farms are milder, Chen's team expects even better results when they move to cattle trials soon.

The Ripple Effect

A successful bovine TB vaccine would transform life for cattle ranchers across Canada and beyond. No more devastating herd depopulations. No more watching generations of careful breeding disappear in a single outbreak.

The vaccine could also restore trade relationships damaged by bovine TB detections and save taxpayers millions in compensation payments to affected producers. The federal government recently had to extend special tax deferrals just to help ranchers cope with TB-related losses.

Chen and his team now need to prove MSX-1 works in actual cattle and figure out exactly how it protects animals. Safety testing is paramount because vaccinated cattle will eventually become food. The researchers also need to confirm the vaccine doesn't slow down weight gain in beef cattle.

"If we are successful, I'm proud to say that this will be a homegrown first in Canada," Chen said. "There is no licensed bovine TB vaccine anywhere in the world."

The next phase involves isolating common TB strains from Prairie farms and testing the vaccine against them in live cattle. Chen calls it the potential highlight of his research career.

For thousands of ranchers who've watched nervously as bovine TB crept closer to their operations, that day can't come soon enough.